Published on the CORDIS, the Community Research and Development Information Service (the European Commission's primary source of results from the projects funded by the EU's framework programmes for research and innovation), a news article on MOAB project, Principal Investigator Manuela Teresa Raimondi, Department of Chemistry, Materials and Chemical Engineering “Giulio Natta”.

First millifluidic bioreactor for better in vitro drug testing

Developing new drugs typically takes at least 10 years and EUR 1 billion. The MOAB-nichoid testing platform offers a realistic drug testing environment which could reduce both failure rates and animal testing.

> View the article